Gamma-delta T cells in neuroblastoma: Exploiting MHC-independent recognition to overcome the barriers of high-risk disease
Translational Oncology · 2027-01 · 75 · 103122
DOI: 10.1016/j.tranon.2026.103122 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Oncology, 2027-01. Verfasst von Samira Mohamadian und 8 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Die Arbeit nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
- Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran; Department of Immunology, School of Medicine, Isfahan University of Medical S…
- Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran; Children's Medical Center, Pediatric Center of Excellence, Tehran University…
- Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: aahamidieh@tums.ac.ir.
Zitieren
APA
Mohamadian, S., Kalantari, A., Farajifard, H., Esmaeil, N., Karimizadeh, Z., Mohseni, R., Ardakani Moghadam, M., Behfar, M., & Hamidieh, A. A. (2027). Gamma-delta T cells in neuroblastoma: Exploiting MHC-independent recognition to overcome the barriers of high-risk disease. Translational Oncology, 75, 103122. https://doi.org/10.1016/j.tranon.2026.103122
Vancouver
Mohamadian S, Kalantari A, Farajifard H, Esmaeil N, Karimizadeh Z, Mohseni R, et al. Gamma-delta T cells in neuroblastoma: Exploiting MHC-independent recognition to overcome the barriers of high-risk disease. Translational Oncology. 2027;75:103122. doi:10.1016/j.tranon.2026.103122
BibTeX
@article{Mohamadian2027,
author = {Mohamadian, Samira and Kalantari, Amirali and Farajifard, Hamid and Esmaeil, Nafiseh and Karimizadeh, Zahra and Mohseni, Rashin and Ardakani Moghadam, Mitra and Behfar, Maryam and Hamidieh, Amir Ali},
title = {Gamma-delta T cells in neuroblastoma: Exploiting MHC-independent recognition to overcome the barriers of high-risk disease},
journal = {Translational Oncology},
year = {2027},
volume = {75},
pages = {103122},
doi = {10.1016/j.tranon.2026.103122}
}
EUVIMED